Sofinnova Investments, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
A detailed history of Sofinnova Investments, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 147,929 shares of ALNY stock, worth $43.9 Million. This represents 1.99% of its overall portfolio holdings.
Number of Shares
147,929
Previous 103,036
43.57%
Holding current value
$43.9 Million
Previous $15.4 Million
133.45%
% of portfolio
1.99%
Previous 0.9%
Shares
8 transactions
Others Institutions Holding ALNY
# of Institutions
618Shares Held
108MCall Options Held
2.33MPut Options Held
2.15M-
Capital World Investors Los Angeles, CA15MShares$4.44 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.71 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.83 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.84 Billion0.28% of portfolio
-
Baillie Gifford & CO6.03MShares$1.79 Billion1.16% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $36.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...